Latest Corinne Goldsmith Dickinson Center for Multiple Sclerosis Stories

2012-01-30 06:08:07

(Ivanhoe Newswire)-- Many of us have heard of or know someone with the dreadful disease known as multiple sclerosis. Affecting approximately 400,000 people in the United States and 2.5 million people worldwide, multiple sclerosis is still incurable and has few effective treatments available. Patients affected by multiple sclerosis are hindered on a daily basis by physical ailments, including fatigue, pain, and difficulty with mobility, as well as problems with social functioning and...

2012-01-11 06:35:56

(Ivanhoe Newswire)-- Recent studies give hope for patients with the irreversible disease known as MS or multiple sclerosis by possibly reversing the aging effects of the central nervous system. Approximately 100,000 people in the United Kingdom, 400,000 in the United States and several million worldwide are affected by MS. With age our bodies' regenerative abilities decrease. While wrinkles allow us to see visible aging effects of skin many other body tissues are left invisibly aging....

2012-01-06 15:13:06

Proof of principle study suggests the age-associated decline of the remyelination process is reversible New research highlights the possibility of reversing ageing in the central nervous system for multiple sclerosis (MS) patients. The study is published today, 06 January, in the journal Cell Stem Cell. As we get older, our bodies' ability to regenerate decreases. This is not only true for our skin (which is evident in the wrinkles that develop as we age) but also true for other tissues...

New Drug Shows Promise Against Multiple Sclerosis
2011-11-02 04:45:28

An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America. It usually strikes young adults and is more common in women than in men. The study, carried out by researchers at UCSF Medical Center, and involving hospitals in the United States, Canada, and Europe, is described this week in the British...

2011-07-20 06:00:00

ST. LOUIS, July 20, 2011 /PRNewswire/ -- Beginning July 29, Mark J. Tullman, MD, board-certified neurologist specializing in the diagnosis and treatment of multiple sclerosis (MS), will join The MS Center for Innovations in Care at Missouri Baptist Medical Center to help patients living with the chronic, often disabling affects of MS. The Center at Missouri Baptist is designated as a National Multiple Sclerosis Society Affiliated Center for Comprehensive Care. "I am extremely pleased to...

2011-04-14 15:27:12

Researchers from Mount Sinai School of Medicine will present several key studies at the American Academy of Neurology (AAN) annual meeting, including research providing critical insight into the prognosis and clinical treatment course of people with a certain subtype of Multiple Sclerosis (MS). The meeting is taking place April 9-16 in Honolulu. In a study titled "Evaluation of Progressive Relapsing MS Patients in the PROMISE Trial," Fred Lublin, MD, Saunders Family Professor of Neurology and...

Word of the Day
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.